French Biopharmaceutical Firm Will Relocate U.S. Business Offices from Basking Ridge, NJ, Over 12-Month Period
International biopharmaceutical group Ipsen is moving its North American headquarters to Cambridge, MA, the Paris-based business divulged at the 2018 BIO International Convention held today at the Boston Convention & & Exhibit Center.
Over the next 12 months, Ipsen (Euronext: IPN; ADR: IPSEY) will shift the core of its North American operations from 106 Allen Rd. in Basking Ridge, NJ, to Cambridge, where the organization will develop its third worldwide biotech hub together with its locations in the UK and France. Ipsen, which signed a six-and-a-half year lease back in 2012 for approximately 30,000 square feet at 106 Allen, verified it will keep a core services center in Basking Ridge.
“We are entering into a new period of development and growth for Ipsen as a leading international biotech business. By bringing our head office to Cambridge, we will construct a sustainable innovation engine to advance chances for our workers and our overall business,” stated Richard Paulson, ceo of Ipsen North America.
Ipsen already has a presence in Cambridge with 2 places in Kendall Square: a manufacturing center at One Kendall Square, and workplaces at 650 E. Kendall St., the home of the company’s worldwide external innovation and partnering, and research study and advancement departments.
Though a particular location within Kendall Square has not been determined, Ipsen said in a release it will combine its worldwide external development and partnering team, and research and advancement departments, with its manufacturing groups and “certain commercial roles.” The relocation is expected to produce 250 brand-new jobs in Cambridge over the next couple of years, according to regional reports.